Kara O’Brien

Company: Novartis AG

Job title: Executive Director - Global Precision Diagnostics Market & Ecosystem Shaping

Seminars:

Panel Discussion: Steering Global Commercialization Landscapes to Usher Liquid Biopsy Assays from Innovation to the Patient to Improve Global Commercial Reach 12:30 pm

• How to ensure liquid biopsy assays are being adequately regulated in the EU vs US vs Japan vs China? • What are regulatory agencies looking for to design the assays? • What are the challenges to bring liquid biopsy technologies to market, related to regulatory approval based on country-specific requirements? • What are the…Read more

day: Day Two Track B AM